Morbid obesity’s impact on COVID-19 patients requiring venovenous extracorporeal membrane oxygenation: The covid-19 critical care consortium database review

Abstract

Introduction: Obesity is associated with a worse prognosis in COVID-19 patients with acute respiratory distress syndrome (ARDS). Veno-venous (V-V) Extracorporeal Membrane Oxygenation (ECMO) can be a rescue option, however, the direct impact of morbid obesity in this select group of patients remains unclear.

Methods: This is an observational study of critically ill adults with COVID-19 and ARDS supported by V-V ECMO. Data are from 82 institutions participating in the COVID-19 Critical Care Consortium international registry. Patients were admitted between 12 January 2020 to 27 April 2021. They were stratified based on Body Mass Index (BMI) at 40 kg/m². The endpoint was survival to hospital discharge.

Results: Complete data available on 354 of 401 patients supported on V-V ECMO. The characteristics of the high BMI (>40 kg/m²) and lower BMI (≤40 kg/m²) groups were statistically similar. However, the ‘high BMI’ group were comparatively younger and had a lower APACHE II score. Using survival analysis, older age (Hazard Ratio, HR 1.49 per-10-years, CI 1.25–1.79) and higher BMI (HR 1.15 per-5 kg/m² increase, CI 1.03–1.28) were associated with a decreased patient survival. A safe BMI threshold above which V-V ECMO would be prohibitive was not apparent and instead, the risk of an adverse outcome increased linearly with BMI.

Conclusion: In COVID-19 patients with severe ARDS who require V-V ECMO, there is an increased risk of death associated with age and BMI. The risk is linear and there is no BMI threshold beyond which the risk for death greatly increases.

Graphical Abstract

Keywords

extracorporeal membrane oxygenation morbid obesity COVID-19 acute respiratory distress syndrome

Get full access to this article

View all access options for this article.

References

Combes

Hajage

Capellier

, et al. Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome. N Engl J Med 2018; 378: 1965–1975.

Peek

Mugford

Tiruvoipati

, et al. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet 2009; 374: 1351–1363.

Davies

Jones

Bailey

, et al. Extracorporeal membrane oxygenation for 2009 Influenza A (H1N1) acute respiratory distress syndrome. JAMA 2009; 302: 1888–1895.

Barbaro

MacLaren

Boonstra

, et al. Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the extracorporeal life support organization registry. Lancet 2020; 396: 1071–1078.

Mohammad

Aziz

Al Mahri

, et al.

Obesity and Covid-19: what makes obese host so vulnerable?

Immun Ageing. 2021; 18: 1.

Kass

. COVID-19 and severe obesity: a big problem? Ann Intern Med 2020; 173: 840–841.

Ford

Giles

Dietz

. Prevalence of the metabolic syndrome among US adults: findings from the third national health and nutrition examination survey. JAMA 2002; 287(3): 356–359.

Grasselli

Greco

Zanella

, et al. Risk factors associated with mortality among patients with COVID-19 in intensive care units in Lombardy, Italy. JAMA Intern Med 2020; 180(10): 1345–1355.

Lighter

Phillips

Hochman

, et al. Obesity in patients younger than 60 years is a risk factor for COVID-19 hospital admission. Clin Infect Dis 2020; 71: 896–897.

10.

Lockhart SM, O’Rahilly S . When Two Pandemics Meet: Why Is Obesity Associated with Increased COVID-19 Mortality? Med (N Y) 2020; 1(1): 33–42.

11.

Javidfar

Zaaqoq

Yamashita

, et al. Venovenous extracorporeal membrane oxygenation in obese patients. JTCVS Tech 2021; 10: 335–348.

12.

Bartlett

Ogino

Brodie

, et al. Initial ELSO guidance document: ECMO for COVID-19 patients with severe cardiopulmonary failure. ASAIO J 2020; 66: 472–474.

13.

COVID-19 critical care consortium. Available at: https://www.covid-critical.com/ (2021, accessed 26 September 2021).

14.

Harris

Taylor

Thielke

, et al. Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics support, J Biomed Inform 2009; 42(2): 377–381.

15.

Harris

Taylor

Minor

, et al. The REDCap consortium: building an international community of software platform partners, J Biomed Inform 2019; 95: 103208.

16.

Zaaqoq

Barnett

Griffee

, et al. Beneficial effect of prone positioning during venovenous extracorporeal membrane oxygenation for coronavirus disease 2019. Crit Care Med 2022; 50(2): 275–285.

17.

Hazard

Kaier

von Cube

, et al. Joint analysis of duration of ventilation, length of intensive care, and mortality of COVID19 patients: a multistate approach. BMC Med Res Methodol 2020; 20: 206.

18.

Noah

Peek

Finney

, et al. Referral to an extracorporeal membrane oxygenation center and mortality among patients with severe 2009 influenza A(H1N1). JAMA 2011; 306: 1659–1668.

19.

Lunn

Jackson

Best

, et al. The bugs book: a practical introduction to bayesian analysis. Chapman & Hall/Crc Texts in Statistical Science. New York: Taylor & Francis, 2012.

20.

Wolkewitz

Cooper

Bonten

MJM

, et al. Interpreting and comparing risks in the presence of competing events. BMJ 2014; 349: g5060.

21.

https://www.r-project.org/, accessed November 1, 2022.

22.

Wasserstein

Lazar

. The ASA statement on p-values: context, process, and purpose. Am Stat 2016; 70: 129–133.

23.

Gray

. Cmprsk: subdistribution analysis of competing risks. Available at: https://CRAN.R-project.org/package=cmprsk (2020, accessed 11 November 2020).

24.

Al-Soufi

Buscher

Nguyen

, et al. Lack of association between body weight and mortality in patients on veno-venous extracorporeal membrane oxygenation. Intensive Care Med 2013; 39(11): 1995–2002.

25.

Kon

Dahi

Evans

, et al. Class III obesity is not a contraindication to venovenous extracorporeal membrane oxygenation support. Ann Thorac Surg 2015; 100(5): 1855–1860.

26.

Swol

Buchwald

Dudda

, et al. Veno-venous extracorporeal membrane oxygenation in obese surgical patients with hypercapinic lung failure. Acta Anaesthesiol Scand 2014; 58(5): 534–538.

27.

Swol

Buchwald

Strauch

, et al. Effect of body mass index on outcome of surgical patients receiving extracorporeal devices (VV ECMO, pECLA) for respiratory failure. Int J Artif Organs 2017; 40: 102–108.

28.

Schmidt

Zogheib

Roze

, et al. The PRESERVE mortality risk score and analysis of long-term outcomes after extracorporeal membrane oxygenation for severe acute respiratory distress syndrome. Intensive Care Med 2013; 39(10): 1704–1713.

29.

Ull

Buchwald

Strauch

, et al. Extremely obese patients treated with venovenous ECMO—an intensivist’s challenge. Am J Emerg Med 2015; 33(11): 1720.e3–1720.e4.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.21 MB